Pavlos Msaouel, MD, PhD, MD Anderson, shares his thoughts on oncology clinical trial with us as well as his personal habits.
Oncology Clinical Trials
Physician’s Weekly has developed an innovative, peer-led initiative designed to transform the way oncologists engage with clinical trials.
A Physician’s Weekly survey recently found that most oncologists discuss clinical trial options in 11-50% of patient ...
The following is a summary of “Disparities in clinical drug trial participation in endometrial cancer: a real-world…
Physician's Weekly would like to better understand, uncover, and address barriers to clinical trial participation while…
A roundup of current clinical trials investigating treatment regimens for patients with breast cancer.
Recent study findings indicate Black patients with endometrial cancer are underrepresented in clinical trials despite higher ...
The following is a summary of "Redefining Clinical Trial Strategic Design to Support Drug Approval in Medical Oncology”…
Underscoring how trials can benefit all members of a community and discussing spirituality may improve enrollment of Black ...
TUESDAY, Oct. 15, 2024 (HealthDay News) -- In the United States, there is a growing reliance on industry to conduct cancer…
Relevant Articles
Sequential mesenchymal stem cells infusions curbed the incidence and severity of acute and chronic graft-versus-host disease.
Part 1 reviews the staging, prognostic factors, minimal residual disease, and diagnosis in CLL/SLL.
Physician's Weekly provides a roundup of phase 3 clinical trials in non-small cell lung cancer that are currently recruiting.
Patients with hematologic malignancies had significantly reduced physical function prior to undergoing stem cell transplant.
Pembrolizumab effectively shrank or eliminated tumors for 90% of patients with unresectable advanced desmoplastic melanoma
The identification of 91% molecular concordance between endometrial and ovarian carcinomas could help risk-stratify patients.
